Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cbd Life Sciences Inc (OP: CBDL )

0.0005 -0.0001 (-16.67%)
Streaming Delayed Price Updated: 12:15 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,476,886
Open 0.0006
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0006
Today's Range 0.0005 - 0.0006
52wk Range 0.0001 - 0.0224
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
Via ACCESSWIRE

Performance

YTD
+400.00%
+400.00%
1 Month
N/A
N/A
3 Month
-44.44%
-44.44%
6 Month
-92.54%
-92.54%
1 Year
+400.00%
+400.00%

More News

Read More
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
Via ACCESSWIRE
CBDNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements
Via ACCESSWIRE
CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024
Via ACCESSWIRE
CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace
Via ACCESSWIRE
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces MOU With New York Dispensary, Poised for Significant Revenue Growth and Shareholder Value
Via ACCESSWIRE
The CBD Vault Exploring China Distribution and JV Opportunities
Via ACCESSWIRE
Vienna Vikings Football Team Signs Partnership Agreement With the CBD Vault
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Welcomes Major Political Endorsement for Cannabis Legalization
Via ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Signs MOU With Large Mushroom Supplement Company
Via ACCESSWIRE
CBDL's Expansion Into New Area Sparks More Revenue Growth + Other Updates
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.